A recent report has raised questions over the omission of a commonly used hair-loss drug, finasteride, from Donald Trump’s latest publicly disclosed medical records, prompting renewed scrutiny of transparency in presidential health reporting.
Washington DC: US President Donald Trump’s latest medical disclosure has drawn attention after a medication he had reportedly used for years was not included in recent records.
The omission of finasteride, a widely prescribed treatment for male-pattern baldness, has led to questions about what is included in official health updates and why certain treatments may no longer appear.
Also Read
According to a report citing the Washington Post, finasteride—marketed under the brand name Propecia—was previously listed among medications used by Trump but does not appear in recent medical disclosures since he returned to the White House.
The latest medical report, released last week, also does not mention the drug, despite its earlier inclusion in his treatment history.
What is finasteride?
Finasteride is a prescription medication used primarily to treat male-pattern baldness and benign prostate enlargement. It is widely used in the United States, with millions of prescriptions filled annually.
While generally considered safe under medical supervision, it has been associated in some cases with side effects such as sexual dysfunction and mood-related changes, including depression.
Why is the omission being discussed?
The absence of the drug from Trump’s disclosed medical records has raised questions among medical experts and commentators about disclosure standards for public officials.
Some health professionals quoted in reports have suggested that the lack of clarity could prompt broader concerns about transparency, particularly when it comes to the health status of a sitting president.
The White House, responding to questions, stated that the report includes “all medications deemed clinically relevant to disclose at this time” and added that no undisclosed conditions affecting health status were omitted.
Broader concerns around presidential health
Trump’s health has been a recurring subject of public discussion since his return to office, with media reports noting visible physical changes and occasional fatigue during public appearances.
Medical analysts cited in US media have previously pointed to issues such as daytime sleep patterns and other age-related health concerns, though no official diagnosis has been publicly confirmed.
In earlier years, Trump’s health disclosures have also attracted scrutiny, including during the COVID-19 period when details of his hospitalisation were later clarified.
What remains unclear?
At this stage, there is no official confirmation that Trump has stopped using finasteride, nor has the White House provided a specific explanation for its omission from recent disclosures.
As a result, questions remain focused on whether the change reflects updated medical judgement, privacy considerations, or a shift in treatment that has not been publicly detailed.
While finasteride itself is a widely used and generally safe medication, its disappearance from Trump’s medical records has triggered renewed debate over transparency in presidential health reporting. However, without official clarification, the significance of the omission remains unverified and open to interpretation.
Published: 05 Jun 2026, 08:40 pm IST
Subscribe to our Newsletter
Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.